Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.69 |
| ▸ | ACE | P12821 | 10/20 | 0.63 |
| ▸ | NPY1R | P25929 | 1/20 | 0.61 |
| ▸ | NPY2R | P49146 | 1/20 | 0.61 |
| ▸ | NPY4R | P50391 | 1/20 | 0.61 |
| ▸ | MME | P08473 | 7/20 | 0.60 |
| ▸ | CPA1 | P15085 | 2/20 | 0.60 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.60 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31067318 | 1.00 | FOLH1 (0.69) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL11056714 | 1.00 | FOLH1 (0.69) | FOLH1ACENPY1RNPY2RNPY4R | |
| Hydrochloric Acid SCHEMBL6473764 | 0.99 | FOLH1 (0.67) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL29822758 | 0.97 | FOLH1 (0.66) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL29350874 | 0.96 | FOLH1 (0.68) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL30792483 | 0.94 | ACE (0.67) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL29802495 | 0.94 | ACE (0.67) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL29379597 | 0.94 | FOLH1 (0.62) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL29734944 | 0.94 | FOLH1 (0.68) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL217352 | 0.93 | FOLH1 (0.60) | FOLH1ACENPY1RNPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | HAIKOU QIAOSHUI UNITED TECHNOLOGY CO. LTD. (CN) | 2026-03-12 | — | — | US | claimed |
| EP-4700039-A1 | PEPTIDE, AND COMPOSITION THEREOF AND USE THEREOF | Winkey Technology USA Inc (US) | 2026-02-25 | — | — | EP | claimed |
| WO-2025065355-A1 | POLYPEPTIDE PROBE AND KIT FOR EARLY DIAGNOSIS OF HUNTINGTON'S DISEASE | 京东方科技集团股份有限公司 | 2025-04-03 | — | — | WO | claimed |
| WO-2025002589-A1 | TISSUE EXTRACELLULAR PEPTIDE PATTERNS DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST SALIVARY GLAND TUMOR, IDENTIFICATION AND ISOLATION OF SALIVARY GLAND TUMOR SPECIFIC T CELLS IN HUMANS | Uniwersytet Gdański (PL) | 2025-01-02 | — | — | WO | claimed |
| US-12169199-B2 | Activity based host cell protein profiling | REGENERON PHARMACEUTICALS, INC. (US) | 2024-12-17 | — | — | US | claimed |
| CN-119080873-A | Ginseng peptide and preparation method and application thereof | 完美（广东）日用品有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118987163-A | Use of sardine peptide-containing composition for improving atopic dermatitis symptoms | 海口桥水联合科技有限责任公司 | 2024-11-22 | — | — | CN | claimed |
| WO-2024235082-A1 | USE OF SARDINE PEPTIDE COMPOSITION IN DRUG FOR TREATING ALLERGIC RHINITIS | 海口桥水联合科技有限责任公司 | 2024-11-21 | — | — | WO | claimed |
| WO-2024217505-A1 | PEPTIDE, AND COMPOSITION THEREOF AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2024-10-24 | — | — | WO | claimed |
| CN-117778510-A | Preparation method of caper bitter peptide | 昆明理工大学 | 2024-03-29 | — | — | CN | claimed |
| CN-116350746-B | Application of sardine peptide composition in medicines for treating allergic rhinitis | 海口桥水联合科技有限责任公司 | 2024-03-22 | — | — | CN | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-116350746-A | Application of sardine peptide composition in medicines for treating allergic rhinitis | 海口桥水联合科技有限责任公司 | 2023-06-30 | — | — | CN | claimed |
| CN-113999287-B | Galectin-10-targeted polypeptide inhibitor and preparation method and application thereof | 深圳湾实验室坪山生物医药研发转化中心 | 2023-06-27 | — | — | CN | claimed |
| CN-109563126-B | Proteasome inhibitors | 马克斯-普朗克科学促进学会 | 2023-06-16 | — | — | CN | claimed |
| EP-4111207-A1 | ACTIVITY BASED HOST CELL PROTEIN PROFILING | Regeneron Pharmaceuticals, Inc. (US) | 2023-01-04 | — | — | EP | claimed |
| CN-115516313-A | Activity-based mass spectrometry of host cell proteins | 瑞泽恩制药公司 | 2022-12-23 | — | — | CN | claimed |
| WO-2022148418-A1 | PHARMACEUTICAL COMPOSITION CAPABLE OF BEING DELIVERED BY METERED DOSE INHALER | 江苏恒瑞医药股份有限公司 | 2022-07-14 | — | — | WO | claimed |
| US-4453941-A | Composition and process for producing pigmentation in hair or skin | BOARD OF OVERSEERS OF GOSHEN COLLEGE (US) | 1984-06-12 | — | — | US | claimed |
| US-4390341-A | Composition and process for producing pigmentation in hair or skin | BOARD OF OVERSEERS OF GOSHEN COLLEGE (US) | 1983-06-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | VIP, ANPEP, RNPEP | FOLH1 274/4885ACE 132/4885NPY1R 438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.